Signal · Supply Chain & Logistics
Jagsonpal Pharma to acquire Group Pharma’s wellness portfolio
What the source reported
Source-reportedJagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals. The acquisition is valued at an initial consideration of Rs 23.7 crore along with an additional amount based on future sales. This move aims to strengthen Jagsonpal's pharmaceutical portfolio and enhance its presence in women's healthcare. Meanwhile, Group Pharma plans to focus its resources on oral care following this divestment.
- Publication
- The Economic Times - Industry · Trade Publication
- Published
- 24th September 2026
- Original report
- economictimes.indiatimes.com
ProcIntel stores what the source published in its feed — a headline, a summary and a link. It does not store or reproduce the full article.
What ProcIntel recorded
ProcIntel-derived- Category
- Supply Chain & Logistics
- Geography
- India
- Organisations
- None identified
- Collected
- 24th September 2026 · 13:56
Initial assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Initial Significance Moderate (20.0/100). Strongest contributor: Likely Event Severity (12.0/30 points). Limiting factor: Geographic Breadth (0.0/10 points). Initial Confidence Low (25.0/100, data sufficiency: Partial). Strongest contributor: Source Authority (20.0/40 points). Limiting factor: Specificity (0.0/20 points).
- Strongest contributor
- Likely Event Severity
- Limiting factor
- Geographic Breadth